Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors
Clinical trial NCT00838539 · COMPLETED
Trial details
- NCT number
- NCT00838539
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.